Trial intelligence / Profile preview

Compound porcine cerebroside and ganglioside injection versus piracetam for craniocerebral injury

ChiCTR2000040466Phase 4Recruiting

Sponsor
Tianjin Medical University General Hospital
Start
Jan 2021
Countries
1
01

Overview

Phase 4, randomised trial of porcine cerebroside + porcine ganglioside in traumatic brain injury (TBI) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Montreal Cognitive Assessment. Started Jan 2021; status: recruiting.

02

Drugs

porcine cerebroside + porcine ganglioside
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on ChiCTR2000040466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call